Lifetech LAmbre™ Left Atrial Appendage Closure System Post-Market Registry

NCT04307927 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-11-29

No results posted yet for this study

Summary

Single-center, single-arm, prospective, post-market study of LAmbre™ LAA Closure System. To evaluate immediate and long term procedural success of Lifetech LAmbre™ occluders in patients.

Conditions

Sponsors & Collaborators

  • Lifetech Scientific (Shenzhen) Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jiangtao Yu, Professor · Katholisches Klinikum Koblenz ·Montabaur

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-14
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04307927 on ClinicalTrials.gov